Accelerate Diagnostics | AXDX - Stock


Accelerate Diagnostics reported $3.22M in Stock for its fiscal quarter ending in June of 2024.



Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Bio-Rad Laboratories USD 740.7M 42.5M Dec/2025
Bruker USD 1.2B 21.7M Sep/2025
Danaher USD 2.49B 185M Dec/2025
Hologic USD 688.5M 9.1M Dec/2025
Illumina USD 564M 26M Dec/2025
Myriad Genetics USD 30.6M 1000K Dec/2025
Pacific Biosciences Of California USD 49.28M 3.87M Dec/2025
Quidel USD 577.6M 36.2M Dec/2025
Revvity USD 379.5M 420K Dec/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025